| Literature DB >> 29415771 |
Jian Zhao1, Guanyu Yu2,3, Mengxi Cai2, Xiao Lei4, Yanyong Yang5, Qijin Wang6, Xiao Zhai7.
Abstract
Several studies have focused on umbilical cord-derived mesenchymal stem cells (UC-MSCs) due to their potential therapeutic effects in a cluster of diseases. However, there has been no bibliometric analysis evaluating the evolution in UC-MSC research. Therefore, this study aimed to assess scientific activity regarding UC-MSC research. Publications on UC-MSCs were retrieved from the Science Citation Index-Expanded (SCI-E) of the Web of Science (WoS) from 1975 to 2017. Statistical analyses were performed using Excel, GraphPad Prism 5, and VOSviewer software. Comparative analyses were employed to assess contributions between different countries, institutes, and researchers. With 21.26 citations per paper, 1206 papers cited 25,517 times were included. Mainland China contributed the most with 558 papers, with the most citations (6858 times) and the highest H-index (43). South Korea ranked first for number of papers per million people and per trillion gross domestic product (GDP). Keywords were stratified into two clusters by VOSviewer software: cluster 1, "treatments and effects"; and cluster 2, "characteristics". The average appearing years (AAY) of keywords in cluster 1 was more recent than that in cluster 2. For promising hotspots, "TNF-α" showed the latest AAY at 2014.09, followed by "migration", "angiogenesis", and "apoptosis". We conclude that the number of publications has been continuously growing dramatically since 2002 and that mainland China and South Korea are the most productive regions. The focus gradually shifts from "characteristics" to "treatments and effects". Attention should be drawn to the latest hotspots, such as "TNF-α", "migration", "angiogenesis", and "apoptosis". Furthermore, funding agencies might increase investments in exploring the therapeutic potential of UC-MSCs.Entities:
Keywords: Bibliometric; Citation; H-index; Hotspots; UC-MSC
Mesh:
Year: 2018 PMID: 29415771 PMCID: PMC5803908 DOI: 10.1186/s13287-018-0785-5
Source DB: PubMed Journal: Stem Cell Res Ther ISSN: 1757-6512 Impact factor: 6.832
Fig. 1Contributive characteristics of UC-MCS research. a The total publications worldwide and the three most productive countries in UC-MCS research. b Model fitting curves of growth trends of accumulated number of publications on UC-MCS worldwide. c The number of publications on UC-MCS research from the top 10 contribution institutes. d The number of publications of the top 10 popular journals on UC-MCS research
Publications in the 10 most productive countries
| Country |
| % | H-index | Total citations | ||
|---|---|---|---|---|---|---|
| Mainland China | 558 | 46.27 | 0.41 | 26.23 | 43 | 6858 |
| South Korea | 160 | 13.27 | 3.14 | 82.94 | 36 | 3838 |
| USA | 136 | 11.28 | 0.42 | 7.33 | 34 | 3949 |
| Iran | 53 | 4.39 | 0.64 | 36.33 | 9 | 289 |
| India | 43 | 3.57 | 0.03 | 4.93 | 15 | 684 |
| Italy | 42 | 3.48 | 0.68 | 18.91 | 17 | 1029 |
| Taiwan | 38 | 3.15 | 1.62 | 33.72 | 19 | 2841 |
| Germany | 37 | 3.07 | 0.46 | 9.30 | 16 | 3395 |
| England | 35 | 2.90 | 0.54 | 12.55 | 14 | 1056 |
| Japan | 29 | 2.40 | 0.23 | 5.88 | 14 | 711 |
GDP gross domestic product
The top 10 related funding agencies
| Funding agency |
| % |
|---|---|---|
| National Natural Science Foundation of China | 255 | 21.14% |
| Jiangsu Province for Outstanding Sci Tech Innovation Team | 16 | 1.33% |
| China Postdoctoral Science Foundation | 16 | 1.33% |
| Fundamental Research Funds for the Central Universities | 13 | 1.08% |
| Natural Science Foundation of Jiangsu Province | 12 | 1.00% |
| National Institutes of Health (NIH) | 12 | 1.00% |
| National Research Foundation of Korea (NRF) | 12 | 1.00% |
| Ministry of Education Science and Technology | 11 | 0.91% |
| National Basic Research Program of China | 10 | 0.83% |
| Ministry of Health And Welfare Republic of Korea | 9 | 0.75% |
The top 10 authors with the most publications related to UC-MSC research
| Author |
| Total citations | H-index | Country | Affiliation |
|---|---|---|---|---|---|
| Oh W | 31 | 1187 | 20 | South Korea | Medipost Co. Ltd., Biomedical Research Institute |
| Han ZC | 30 | 1014 | 15 | China | Chinese Academy of Medical Sciences, Peking Union Medical College |
| Xu WR | 30 | 943 | 13 | China | School of Medicine, Jiangsu University |
| Choi SJ | 27 | 754 | 14 | South Korea | Medipost Co. Ltd., Biomedical Research Institute |
| Qian H | 26 | 756 | 12 | China | School of Medicine, Jiangsu University |
| Yang YS | 26 | 871 | 17 | South Korea | Medipost Co. Ltd., Biomedical Research Institute |
| Zhang X | 22 | 555 | 11 | China | School of Medicine, Jiangsu University |
| Zhu W | 22 | 752 | 12 | China | School of Medicine, Jiangsu University |
| Kang KS | 21 | 441 | 13 | South Korea | Seoul National University, College of Veterinary Medicine |
| Yan YM | 21 | 665 | 10 | China | School of Medicine, Jiangsu University |
UC-MSC umbilical cord-derived mesenchymal stem cell
The top 10 UC-MSC research papers with the most citation frequency
| Title | First author | Journal | Year | Citations | Citation frequency per year | Main conclusion |
|---|---|---|---|---|---|---|
| Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue | Kern | Stem Cells | 2006 | 1382 | 115.17 | They compared MSCs derived from umbilical cord blood, bone marrow, and adipose tissue regarding morphology, the success rate of isolating MSCs, colony frequency, expansion potential, multiple differentiation capacity, and immune phenotype |
| Isolation of multipotent mesenchymal stem cells from umbilical cord blood | Lee | Blood | 2004 | 819 | 58.5 | They reported a novel method to obtain single cell-derived, clonally expanded MSCs that are of multilineage differentiation potential |
| Mesenchymal stem cells in the Wharton’s jelly of the human umbilical cord | Wang | Stem Cells | 2004 | 665 | 47.5 | UC-MSC express matrix receptors (CD44, CD105) and integrin markers (CD29, CD51), and can differentiate into cardiomyocytes |
| Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood | Wagner | Experimental Hematology | 2005 | 660 | 50.77 | They provided a foundation for a more reproducible and reliable quality control using genotypic analysis for defining MSCs |
| Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood | Bieback | Stem Cells | 2004 | 510 | 36.43 | MSC-like cells can be isolated at high efficacy from full-term UC donations; we regard UC as an additional stem cell source for experimental and potentially clinical purposes |
| Searching for alternative sources of postnatal human mesenchymal stem cells: Candidate MSC-like cells from umbilical cord | Romanov | Stem Cells | 2003 | 505 | 33.67 | UC vasculature contains a high number of MSC-like elements forming colonies of fibroblastoid cells that may be successfully expanded in culture |
| Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow | Baksh | Stem Cells | 2007 | 457 | 41.55 | They compared HUCPVCs to the “gold standard” bone marrow mesenchymal stromal cells (BMSCs) with respect to their proliferation, differentiation, and transfection capacities |
| Adult bone marrow is a rich source of human mesenchymal ‘stem’ cells but umbilical cord and mobilized adult blood are not | Wexler | British Journal of Haematology | 2003 | 384 | 25.6 | Adult BM is a reliable source of functional cultured MSCs, but cord blood and peripheral blood stem cell collections are not |
| Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials | Lu | Haematologica | 2006 | 381 | 31.75 | They established a protocol to isolate abundant MSCs from human umbilical cords with a 100% success rate. The comparative study indicates that UC is an excellent alternative to BM as a source of MSCs for cell therapies. |
| Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice | Noort | Experimental Hematology | 2002 | 315 | 19.69 | Upon co-transplantation, MSCs, but not irradiated CD34− or B cells, promote engraftment of UCB CD34+ cells in bone marrow, spleen, and blood. |
BM bone marrow, HUCPVC human umbilical cord perivascular cell, MSC mesenchymal stem cell, UC umbilical cord, UCB umbilical cord blood
Fig. 2The mapping on keywords of UC-MCS. a The keywords were divided into two clusters: cluster 1, “treatments and effects”; and cluster 2, “characteristics”. In general, the smaller the distance between two terms, the larger the number of co-occurrences of the terms. The size of the circle represents the frequency of the keyword, with a larger circle indicating the keyword appears more frequently. b Based on the average time of appearance, keywords in blue presented earlier than those in yellow and red